Animal Model Market Size, Share & Trends Report

Animal Model Market Size, Share & Trends Analysis Report By Animal Type (Mice, Guinea Pigs), By Application (Cancer, Infectious Disease), By End-use (CRO, Academic Research Institute), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-106-8
Number of Pages: 130
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Animal Model Animal Type Scope Outlook (Revenue, USD Million, 2018 - 2030)
- Mice
- Rat
- Guinea Pigs
- Rabbits
- Hamsters
- Others
Animal Model Application Scope Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer
- Immunological Disease
- Infectious Disease
- Others
Animal Model End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical & Biotechnology Companies
- Academic Research Institute
- Contract Research Organization
Animal Model Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Mice
    - Rat
    - Guinea Pigs
    - Rabbits
    - Hamsters
    - Others
  - North America Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Cancer
    - Immunological Disease
    - Infectious Disease
    - Others
  - North America End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical & Biotechnology Companies
    - Academic Research Institute
    - Contract Research Organization
  - U.S.
    - U.S. Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - U.S. Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - U.S. End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - Canada
    - Canada Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Canada Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Canada End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
- Europe
  - Europe Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Mice
    - Rat
    - Guinea Pigs
    - Rabbits
    - Hamsters
    - Others
  - Europe Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Cancer
    - Immunological Disease
    - Infectious Disease
    - Others
  - Europe End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical & Biotechnology Companies
    - Academic Research Institute
    - Contract Research Organization
  - Germany
    - Germany Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Germany Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Germany End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - UK
    - UK Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - UK Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - UK End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - France
    - France Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - France Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - France End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - Italy
    - Italy Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Italy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Italy End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - Spain
    - Spain Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Spain Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Spain End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - Denmark
    - Denmark Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Denmark Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Denmark End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - Sweden
    - Sweden Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Sweden Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Sweden End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - Norway
    - Norway Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Norway Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Norway End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
- Asia Pacific
  - Asia Pacific Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Mice
    - Rat
    - Guinea Pigs
    - Rabbits
    - Hamsters
    - Others
  - Asia Pacific Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Cancer
    - Immunological Disease
    - Infectious Disease
    - Others
  - Asia Pacific End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical & Biotechnology Companies
    - Academic Research Institute
    - Contract Research Organization
  - China
    - China Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - China Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - China End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - India
    - India Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - India Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - India End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - Japan
    - Japan Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Japan Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Japan End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - South Korea
    - South Korea Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - South Korea Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - South Korea End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - Australia
    - Australia Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Australia Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Australia End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - Thailand
    - Thailand Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Thailand Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Thailand End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
- Latin America
  - Latin America Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Mice
    - Rat
    - Guinea Pigs
    - Rabbits
    - Hamsters
    - Others
  - Latin America Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Cancer
    - Immunological Disease
    - Infectious Disease
    - Others
  - Latin America End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical & Biotechnology Companies
    - Academic Research Institute
    - Contract Research Organization
  - Brazil
    - Brazil Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Brazil Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Brazil End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - Mexico
    - Mexico Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Mexico Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Mexico End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - Argentina
    - Argentina Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Argentina Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Argentina End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
- Middle East and Africa (MEA)
  - Middle East and Africa (MEA) Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Mice
    - Rat
    - Guinea Pigs
    - Rabbits
    - Hamsters
    - Others
  - Middle East and Africa (MEA) Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Cancer
    - Immunological Disease
    - Infectious Disease
    - Others
  - Middle East and Africa (MEA) End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical & Biotechnology Companies
    - Academic Research Institute
    - Contract Research Organization
  - South Africa
    - South Africa Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - South Africa Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - South Africa End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - South Africa
    - South Africa Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - South Africa Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - South Africa End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - UAE
    - UAE Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - UAE Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - UAE End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization
  - Kuwait
    - Kuwait Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Mice
      - Rat
      - Guinea Pigs
      - Rabbits
      - Hamsters
      - Others
    - Kuwait Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Cancer
      - Immunological Disease
      - Infectious Disease
      - Others
    - Kuwait End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical & Biotechnology Companies
      - Academic Research Institute
      - Contract Research Organization

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.